iPSCs-based generation of vascular cells: reprogramming approaches and applications.

iPSCs-based generation of vascular cells: reprogramming approaches and applications.
复制标题

DOI:
10.1007/s00018-017-2730-7
复制
发表时间:
2018-04
期刊:
Cellular and molecular life sciences : CMLS
影响因子:
--
通讯作者:
Klein D
Klein D
中科院分区:
其他
文献类型:
--
作者:
Klein D

文献摘要

参考文献

被引文献

相似文献

诱导多能干细胞(iPSC)研究领域的最新进展为基于干细胞的血管细胞生成开辟了新途径。基于其生长和分化潜力,人类 iPSC 构成了一种特征明确、通常无限的细胞来源,可用于大规模生成谱系和患者特异性血管细胞,而无需任何伦理问题。人类 iPSC 来源的血管细胞非常适合血管疾病建模研究,因为患者来源的 iPSC 具有致病突变,这可能对疾病表型的全面表达具有决定性作用。将血管细胞应用于自体细胞替代疗法或源自免疫相容性 iPSC 的血管工程具有巨大的临床潜力,但用于再生细胞疗法的血管特异性谱系的大规模生产取决于明确、高度可重复的培养和分化条件。本综述将重点关注从人类 iPSC 中获取血管细胞的不同策略及其在再生治疗、疾病建模和药物发现方法中的应用。
Recent advances in the field of induced pluripotent stem cells (iPSCs) research have opened a new avenue for stem cell-based generation of vascular cells. Based on their growth and differentiation potential, human iPSCs constitute a well-characterized, generally unlimited cell source for the mass generation of lineage- and patient-specific vascular cells without any ethical concerns. Human iPSCs-derived vascular cells are perfectly suited for vascular disease modeling studies because patient-derived iPSCs possess the disease-causing mutation, which might be decisive for full expression of the disease phenotype. The application of vascular cells for autologous cell replacement therapy or vascular engineering derived from immune-compatible iPSCs possesses huge clinical potential, but the large-scale production of vascular-specific lineages for regenerative cell therapies depends on well-defined, highly reproducible culture and differentiation conditions. This review will focus on the different strategies to derive vascular cells from human iPSCs and their applications in regenerative therapy, disease modeling and drug discovery approaches.
DOI: 10.1038/nprot.2012.130
发表时间: 2012-11
期刊: Nature protocols
影响因子: 14.8
作者:
通讯作者: --
MicroRNA-199b 通过靶向 Notch 配体 Jagged1 并增强 VEGF 信号传导来调节 iPS 细胞分化过程中的血管细胞命运
DOI: 10.1002/stem.1930
发表时间: 2015-05
期刊: Stem cells (Dayton, Ohio)
影响因子: --
作者:
Chen T;Margariti A;Kelaini S;Cochrane A;Guha ST;Hu Y;Stitt AW;Zhang L;Xu Q
通讯作者: Xu Q
DOI: 10.1002/sctm.17-0004
发表时间: 2017-08
影响因子: 6
作者:
Collado MS;Cole BK;Figler RA;Lawson M;Manka D;Simmers MB;Hoang S;Serrano F;Blackman BR;Sinha S;Wamhoff BR
通讯作者: Wamhoff BR
DOI: 10.1074/jbc.m113.495531
发表时间: 2014-02-07
期刊: The Journal of biological chemistry
影响因子: --
作者:
Di Bernardini E;Campagnolo P;Margariti A;Zampetaki A;Karamariti E;Hu Y;Xu Q
通讯作者: Xu Q
DOI: 10.1038/nature08195
发表时间: 2009-08-06
期刊: Nature
影响因子: 64.8
作者:
Cordes KR;Sheehy NT;White MP;Berry EC;Morton SU;Muth AN;Lee TH;Miano JM;Ivey KN;Srivastava D
通讯作者: Srivastava D